SCHEMBL7414742

SCHEMBL7414742

CCOC(=O)C[C@H](NC(=O)CNC(=O)CCCCN)c1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.47
ITGB3 P05106 7/20 0.40
ITGA2B P08514 5/20 0.40
ITGAV P06756 5/20 0.40
GAA P10253 1/20 0.40
TBXAS1 P24557 3/20 0.40
HDAC4 P56524 1/20 0.40
MEF2D Q14814 1/20 0.40
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
ITGB5 P18084 2/20 0.39
ITGB6 P18564 2/20 0.39
ROCK2 O75116 1/20 0.39
MAPT P10636 1/20 0.38
FAAH O00519 2/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7414738 0.99 CYP3A4 (0.46) CYP3A4ITGB3ITGA2BITGAVGAA
Hydrochloric Acid SCHEMBL7414735 0.99 CYP3A4 (0.46) CYP3A4ITGB3ITGA2BITGAVGAA
SCHEMBL6952526 0.87 ITGB3 (0.43) CYP3A4ITGB3ITGA2BITGAVGAA
SCHEMBL6949822 0.87 ITGB3 (0.44) CYP3A4ITGB3ITGA2BITGAVGAA
SCHEMBL7381193 0.85 CYP3A4 (0.55) CYP3A4ITGB3ITGA2BITGAVGAA
SCHEMBL7381192 0.85 CYP3A4 (0.55) CYP3A4ITGB3ITGA2BITGAVGAA
SCHEMBL7373638 0.83 ITGB3 (0.44) ITGB3ITGA2BITGAVGAAROCK2
SCHEMBL6739002 0.83 ITGB3 (0.44) ITGB3ITGA2BITGAVGAAROCK2
Hydrochloric Acid SCHEMBL7138528 0.82 ITGB3 (0.44) ITGB3ITGA2BITGAVGAAROCK2
Hydrochloric Acid SCHEMBL7991653 0.82 ITGB3 (0.44) ITGB3ITGA2BITGAVGAAROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294549-B1 COMPOUNDS USEFUL FOR INHIBITING RESTENOSIS, ANGIOGENESIS, ATHEROSCLEROSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, INFLAMMATION OR TUMOR GROWTH. MERCK & CO., INC. 2001-09-25 US disclosed
EP-0880511-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1999-06-16 EP disclosed
EP-0880511-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-12-02 EP disclosed
WO-1997026250-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1997-07-24 WO disclosed